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Abstract
Background: A common treatment option for men with prostate cancer is androgen deprivation therapy (ADT).
However, men undergoing ADT may experience physical side effects, changes in quality of life and sometimes
psychiatric and cognitive side effects.
Methods: In this study, hormone naïve patients without evidence of metastases with a rising PSA were treated
with nine months of ADT. Functional magnetic resonance imaging (fMRI) of the brain during three visuospatial
tasks was performed at baseline prior to treatment and after nine months of ADT in five subjects. Seven healthy
control patients, underwent neuroimaging at the same time intervals.
Results: ADT patients showed reduced, task-related BOLD-fMRI activation during treatment that was not observed
in control subjects. Reduction in activation in right parietal-occipital regions from baseline was observed during
recall of the spatial location of objects and mental rotation.
Conclusions: Findings, while preliminary, suggest that ADT reduces task-related neural activation in brain regions
that are involved in mental rotation and accurate recall of spatial information.
Background
Prostate cancer is the most common form of non-skin
cancer diagnosed in U.S. men with over 218,000 newly
diagnosed cases each year estimated per year [1]. While
androgen deprivation therapy (ADT) used to be reserved
for those with metastatic disease and resulted in a med-
ian survival of 2-5 years [2,3], ADT is now commonly
prescribed in the setting of localized disease (e.g. in
combination with radiation therapy) or for the 22% of
patients who fail primary therapy and have a rising PSA
without evidence of metastases [4]. In contrast to those
with metastatic disease the latter patients often have no
disease related symptoms and may live for many years.
Physiological consequences of androgen deprivation
include obesity, anemia, loss of bone mineral density,
muscle atrophy, gynecomastia and mood changes
[2,5,6]. A recent population based study showed that
ADT was associated with an increased risk of diabetes,
myocardial infarction, and hypertension [7]. Psychiatric
changes can include depression and anxiety [8] and cog-
nitive problems can include impairments in verbal
memory [9,10], spatial reasoning [11] and attention [12].
Given these cognitive and medical side effects of ADT
understanding the immediate and long-term conse-
quence of treatment is essential.
Based on findings from our previous study demon-
strating a decline in spatial reasoning abilities in healthy
men undergoing ADT [11], the aim of this study was to
examine if neural activation changes were evident in
response to androgen deprivation while performing spa-
tial reasoning and spatial memory tasks using functional
magnetic resonance imaging (fMRI). Spatial reasoning
and spatial memory were specifically chosen to examine
the effects of ADT on brain function because task-
related brain activation has been clearly identified, parti-
cularly in regions of the parietal cortex [13-16] along
with evidence of hormone influences on these brain
regions [17-19]. The aim of the present study was to
assess changes in neural activation in response to andro-
gen deprivation using functional magnetic resonance
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ADT would show reduced activation in the task-related
parietal region during spatial reasoning and spatial
memory tasks compared to baseline and to healthy
controls.
Methods
Participants
Participants were a subset of participants from a larger
study examining cognitive and mood changes in ADT
who agreed to the additional neuroimaging procedures
(See [20] for details). The sample is a convenience sam-
ple comprised of those participants who were willing to
undergo neuroimaging procedures in addition to the
cognitive assessment procedures in the larger study.
Twelve prostate cancer patients with rising PSA (bio-
chemical relapse) following primary therapy (radiation,
brachytherapy or prostatectomy) in which intermittent
androgen suppression (ADT) therapy is indicated were
eligible and gave informed consent to participate. Inter-
mittent ADT is a treatment strategy that cycles andro-
gen withdrawal with an “off treatment” period allowing
the testosterone levels to return to eugonadal levels.
This approach has allowed for characterization of the
biological, psychological, and quality of life effects of
ADT and which effects are reversible or attenuated
when the testosterone levels increase during the ‘off
treatment’ period. Additional eligibility criteria included
age greater than 21 years, no disturbance in daily func-
tioning and normal pretreatment serum testosterone.
Exclusion criteria included moderate pain related to
prostate cancer, history of prior psychiatric illness invol-
ving hospitalization, dementia, central nervous system
metastasis, history of systemic chemotherapy, current
renal dysfunction or hepatic dysfunction, prior exposure
to welding or any surgery resulting in metal implants in
the brain or presence of any unusual findings from mag-
netic resonance imaging (MRI). The University of
Washington Institutional Review Board approved this
study and written informed consent was obtained from
all patients prior to study procedures. A placebo or
non-treated group in this population was not feasible,
therefore a comparable non-treatment group of twelve
community dwelling eugonadal men without prostate
cancer range matched for age within four years and edu-
cation within two years underwent the same neuroima-
ging procedures at a matching time interval to the ADT
group. Radiology technicians who performed scanning
operations were blind to conditions. Imaging data were
identified only by coded numbers and group member-
ship was coded during image analysis.
Study Design
Baseline evaluations for ADT patients included a bone
scan, CT scan of the abdomen and pelvis, chest x-ray,
cognitive function testing, and baseline laboratory values
including renal and hepatic function, PSA and total tes-
tosterone. Patients were treated with an anti-androgen
(flutamide 250 mg TID or bicalutamide 50 mg per day
if intolerant of flutamide) lead-in alone for 2 weeks fol-
lowed by the addition of leuprolide 7.5 mg administered
by monthly intramuscular injection for nine doses.
Thereafter, the PSA was followed monthly. The ADT
group underwent neuroimaging procedures prior to the
start of treatment (time1) and again after nine months
of androgen deprivation (time2). The control group
underwent two neuroimaging sessions nine months
apart. In addition to high resolution structural scans,
subjects underwent blood oxygen level dependent
(BOLD) -fMRI imaging while performing three cognitive
tasks; i) encoding and ii) recognition in a spatial mem-
ory task and iii) a mental rotation task.
Environmental Memory Task (EMT)
An environmental memory task designed by Shelton
and colleagues [21,22] was used for a spatial memory
task. The task was modified for older individuals by
using a single environment (either a park or market)
during both encoding and recognition portions and
allowing subjects 6 seconds (rather then 3) to identify
still images during recognition. This task is composed of
separate, sequentially presented encoding and recogni-
tion runs lasting 348 and 478 seconds, respectively.
During both encoding and recognition the environ-
ment is viewed from the ground (route) and the aerial
(survey) perspective in an alternating, pseudorandom
order. To ensure that subjects were familiar with identi-
fying objects from the route and survey perspective and
that they understood the requirements of the task they
completed a practice session outside the MRI suite with
an environment not subsequently used during the scan-
ning session. All subjects demonstrated satisfactory
understanding and performance of the task after this
practice session and the practice session was repeated at
the second visit. During the fMRI session verbal instruc-
tions were provided though headphones and visual sti-
muli through goggles connected via high-resolution
fiber optic cables. Stimuli were presented using an
Apple computer running PsyScope [23]. Radiology tech-
nicians who were responsible for scanning the partici-
pants were blind to condition and only subject numbers
identified the imaging data.
Encoding task (ENCODE)
During the encoding task subjects viewed animated
movies of an environment (either a park or market) pre-
sented from both the route perspective and the survey
perspective. The environment was shown six times, 3×
from the route and 3× from the survey perspective, in
an alternating psuedorandom order. The individual
movies were 46 seconds long and were preceded by
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(cross-hair) were intermixed in the sequence. The run was
thus composed of 3 fixation blocks (18s each) + 3 repeti-
tions of the route perspective movie (46+3s each) + 3
repetitions of the survey perspective movie (46+3s each) in
for a total run time or 348 s (116 volumes, TR = 3). Imme-
diately following encoding subjects were tested on their
knowledge of the complex environment during the recog-
nition task (see below). Subjects were informed that their
memory for the environment would be subsequently
tested but active responses were not required during
encoding.
Recognition task (RECOG)
During the recognition run subjects viewed still images
of the previously studied environment and determined if
objects within the environment were; (i) correctly posi-
tioned (previously seen items in appropriate environ-
mental locations), (ii) spatially rearranged (previously
seen items shuffled within the environment), or (iii) they
could not tell (do not know). A total of 64 images were
presented; 32 from the route perspective (4 blocks of 8
images, each block preceded by 3 s of fixation) and 32
images from the survey perspective (4 blocks of 8 images,
each block preceded by 3 s of fixation). Each set of 8
images contained four spatially correct images and four
foils or incorrect choices with the order randomized.
Four, 18 s fixation blocks (cross-hair) were intermixed
in the sequence. The entire run was thus composed of 4
fixation blocks (18s each) + 4 route perspective picture
blocks (48+3s each) + 4 survey perspective picture
blocks (48+3s each) in a quasi-random order for a total
run time of 480s (160 volumes, TR = 3). Following the
fMRI session subjects were asked to draw the environ-
ment to ensure they had completed the task appropri-
ately (data not scored).
Mental Rotation Matching Task (MATCH)
Participants were shown black and white complex, three
dimensional (3D) figures taken from the Shephard and
Metzler Mental Rotation test [24,25] or complex and
abstract two dimensional (2D) figures in black/white/
gray. Participants were asked to determine if the figures
(i) matched exactly or, (ii) they did not match or, (iii)
did not know. Incorrect matches for the three-dimen-
sion figures were either mirror images or a different
configuration whereas a match was the same image side
by side, although the images may have been rotated in
space. For the 2D- images, a match was the same image
side by side, whereas a mis-match involved one of the
figures having additional details or missing details.
Stimuli were presented using Eprime® software http://
www.pstnet.com/products/e-prime/ and responses were
recorded using magnet compatible buttons. For 3D-fig-
ures a total of 15 figures were presented (3 blocks of 5
images, each block preceded by 6 seconds of
instruction) and for 2D-figures a total of 18 images were
presented (3 blocks of 10 images, each block preceded
by 6 seconds of instruction). Four, 18 s fixation blocks
(cross-hair) were inter-mixed in the sequence. The
entire run was thus composed of 4 fixation blocks (18 s
each) + 6 figure matching blocks + 6 instruction periods
for a total run time of 468 second scan (156 volumes,
TR = 3).
BOLD imaging
Structural and functional MRI were performed on a 1.5
T MR imaging system (General Electric, Waukesha,
WI). Whole brain axial anatomic (21 images, TR/TE
200/2.2 ms) and functional (21 images, TR/TE 3000/
50 ms, flip angle 90°, 64 × 64 matrix, in-plane resolution
of 3.75 × 3.75 mm, slice thickness 6 mm with 1 mm
spaces) images were collected using a two-dimensional
gradient-echo, echo-planar pulse sequence.
Functional image analysis
Functional data were processed using tools from the
FMRIB Software Library (http://www.fmrib.ox.ac.uk and
Smith et al., 2004) in essentially 6 steps (see Table 1):
STEP 1) Independent components analysis based artifact
detection and component removal, STEP 2) first-level
analysis of individual paradigms for each subject; STEP
3) second-level fixed-effects analysis of individual sub-
ject’s time1 vs. time2 scans; STEP 4) group mixed-effects
general linear model comparison of ADT treated and
CTR groups and, STEP 5) group mixed-effects compari-
son of baseline (time1) vs. treatment (time2) activation
changes in each group for the individual tasks; STEP 6)
Using paradigm specific ROIs defined by STEP 5 (i.e., a
unique ROI for ENCODE, RECOG and MATCH) the
average change in the z-score between time1 and time2
was determined for each subject and task.
STEP 1: Motion correction [26], spatial smoothing
with a 7 mm at half-maximum Gaussian kernel and low
pass (sigma = 2.8 s) and high pass (sigma = 75 s) filters
were applied. Absolute motion varied from 0.1 to 1.2
mm and relative motion varied between 0.04 and 0.22
mm. Data were then analyzed using probabilististic
independent components analysis (ICA) (MELODIC)
[27] to identify extreme scanning artifacts and the corre-
sponding components were removed. 4-10 components
r e m o v e df r o m4o f2 4E N C O D Es c a n s( 1A D Ta n d1
CTR subject) and 2 or 24 MATCH scans (1 CTR sub-
ject). No RECOG scan needed correction. STEP 2: The
initial 6 volumes of each functional series were dis-
carded to allow T1 equilibrium. For each task three
separate explanatory variables (EVs) plus 6 motion para-
meters of no interest were modeled. For each subject
and each task, four individual contrasts were designed
to determine task-related activation, deactivation, and
the difference between route/survey in the EMT and
3D/2D in the MATCH tasks. STEP 3: Each subject’s
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structural images using 7 DOF and into standard space
(MNI152 brain) with a 12 DOF affine transformation
[28]. Registration was confirmed by visual inspection
and manually re-aligned as appropriate. Individually for
each subject, task-related activation at time1 was com-
pared to time2 using a fixed-effects paired t-test. This
allowed us to assess the change in task-related activation
averaged across the three tasks for each subject. STEP 4:
Between-group comparisons were done using a full
mixed-effects GLM using the parameter estimates from
STEP 3 as inputs [29,30] and activated clusters were
identified based on random field theory correcting for
multiple comparisons (FLAME). STEP 5: A post-hoc
region of interest (ROI) analysis was performed sepa-
rately for each paradigm to determine how time1 vs.
time2 changes in the individual paradigm contributed to
the findings in STEP 4. For STEP 4 a z-threshold of 2.7
and p < 0.01 was set to minimize type 1 error while for
STEP 5 stringency was relaxed by decreasing the z-
threshold to 2.0 and p < 0.05 to reduce type 2 error.
STEP 6: A unique statistically defined ROI was
generated for each paradigm corresponding to the
region where ΔADT > ΔCTR (RECOG and MATCH) or
ADTtime1 >A D T time2 ∩ CTRtime1 >C T R time2
(ENCODE). These three paradigm specific ROIs were
used in the calculation of the average z-scores for indivi-
dual subjects during the corresponding tasks within the
parietal lobe.
Results
Both ADT patients and controls (CTR) ranged in age
from 56 to 78 years with a mean age of 65 years and
education ranged from 12 to 21 years with a mean edu-
cation level of 17 years. Because the groups were range
matched on age and education they were not signifi-
cantly different on these demographic variables. One
CTR and one ADT participant dropped out prior to
baseline scanning due to concerns about ‘feeling closed
in’ in the scanner. One CTR participant and two ADT
patients did not complete the month 9 imaging session
due to scheduling conflicts. Three CTR and ADT
patients were not analyzed due to excessive motion. In
all, seven controls and five ADT patients were included
Table 1 SUMMARY OF STATISTICAL COMPARISONS
Inputs EVs in model Output/contrasts
STEP 1: ENCODE data n.a. ENCODE* data
ICA data review (Separate for each
paradigm and subject)
RECOG data RECOG* data
MATCH data MATCH* data
STEP 2: ENCODE* data EV1: route (or 3D) C11 = EV1-EV2
Subject paradigm analysis (Separate
for each paradigm and subject)
RECOG* data EV2: survey (or 2D) C12 = EV2-EV1
MATCH* data EV3: fixation C13 = (EV1+EV2)-2*EV3
EV4-9: motion parameters of no
interest
C14 = 2*EV3-(EV1+EV2)
STEP 3:C 13 from each paradigm EV1: time1 > time2 C21 = EV1
Intra-subject analysis (Separate for
each subject)
EV2-4: paired t-test parameters of no
interest
C22 = -EV1
STEP 4:C 21 from each subject EV1: ADT C31 = EV1
Group time1 vs. time2 analysis EV2: CTR C32 = -EV1
C33 = EV2
C34 = -EV2
C35 = EV1-EV2
C36 = EV2-EV1
STEP 5:C 11o rC 13 from each subject EV1: ADTtime1 > ADTtime2 C41 = EV1
Group paradigm analysis (Separate
for each paradigm)
EV2: CTRtime1 > CTRtime2 C42 = -EV1
EV3-14: paired t-test C43 = EV2
parameters of no interest C44 = -EV2
C45 = EV1-EV2
C46 = EV2-EV1
STEP 6:C 13 from each subject n.a. n.a.
Determining average z-scores
(Separate for each paradigm and
subject)
Independent components analysis (ICA), explanatory variable (EV), contrast (C)
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handed. Each subject was scanned twice (baseline, 9
months) with 24 scans sessions and three tasks for a
total of 72 runs included in the analysis. Similar to
other functional neuroimaging studies, variance in the
BOLD signal for our study, for most brain regions
across all paradigms was about 1% of the total signal.
Given the design of our paradigms this would allow us
to detect a 0.5% increase in signal (task-associated acti-
vation) with about 50% power and 0.75% change with >
80%power in individual subjects. Review of clusters of
significant task-associated activation within individual
subjects revealed, as expected from the simplistic prior
power calculation, signal changes ranged 0.25-1.0% of
the signal (data not shown)
As expected, total testosterone was reduced signifi-
cantly in the treatment group at the time of the second
scan compared to the control group F(1,9) = 37.6,
p < .01 and a significant group by time interaction F
(1,9) 53.26, p < .01 was evident. The ADT group total
serum testosterone levels declined from an average of
3.52 (0.33) ng/ml at baseline to 0.25 (0.10) at month 9.
The control group did not change with a baseline tes-
tosterone of 3.8 (0.67) ng/ml and a month 9 average of
4.3 (1.3) ng/ml.
In scanner behavioral performance on the environ-
mental memory task (EMT) or mental rotation did not
change significantly for either group, 36.0 (10) average
total correct EMT (64 points possible) at time1 and
35.75 (13.6) at time2 for ADT group and 31.3 (13.5) at
time1 and 38.0 (10.9) at time2 for control group.
To determine whether ADT affected neurovascular
responses during these tasks, BOLD-fMRI was acquired
prior to treatment (time1) and after 9-months of ADT
(or no treatment in the control group) (time2) in both
the ADT and CTR groups. Task-related activation,
defined as the difference in the BOLD signal between
the active tasks (which differ between paradigms) and
viewing crosshairs (fixation), was reduced in a single
right parietal region in the ADT group but not the CTR
group (Figure 1). This region extended superiorly from
the right precuneal area and inferiorly to the lateral
occipital lobe. BOLD responses during individual para-
digms were differentially affected (Table 2 and Figure 2).
Task-related activation in this region was reduced in
both the ADT and CTR groups during ENCODE. In
contrast, during RECOG and MATCH, task-related acti-
vation was reduced within the ADT group but not the
CTR group and was significantly different between
groups. To ensure these findings were not the result of
an activation difference between groups at time1 an
intergroup analysis was performed for each paradigm.
No activation differences at time1 were found between
groups.
Discussion
Our results indicate androgen deprivation therapy (ADT)
patients had reduced task-related BOLD-fMRI activation
following androgen deprivation in the right parietal-occi-
pital region for tasks involving manipulation and recall of
spatial information. Although in scanner performance
did not decline for either task in this small sample the
observed reduced task-related activation may help
explain our previous findings of impaired rotational abil-
ities in a larger sample of men undergoing ADT [11,20].
Cognitive changes in men undergoing ADT using paper
and pencil and computerized tests have found impair-
ments in verbal memory [9,10], spatial abilities [11,20]
and attention [12]. However, declines may be evident for
only a subset of participants [31], and some studies have
found no appreciable change in cognition from androgen
ablation therapy [32]. These findings suggest that gonadal
steroids modulate parietal-occipital function and are con-
sistent with a report correlating endogenous testosterone
levels and neural activation in the inferior parietal lobule
and left supramarginal gyrus regions while performing a
mental rotation task [18].
Neuroimaging studies of mental rotation have gener-
ally found that rotation of three dimensional figures
engages occipital and parietal regions with numerous
studies supporting the role of the superior parietal
lobule in the performance of mental rotation [33,34].
Gender differences have been reported suggesting that
women engage or recruit additional brain regions such
as the frontal lobes, however the parietal region appears
to be reliably activated by both genders [17,35,36]. Sev-
eral studies but not all [17] have suggested that men
outperform women on the mental rotation task [37]
with some evidence for a positive relationship between
performance on the task and circulating T levels [38,39].
Our results are certainly consistent with these previous
Figure 1 Reduced left parietal activation in the ADT group at
time2. Four sections of a standardized brain with the area of
reduced activation in the ADT group are shown (outlined by the
green circle). No other areas of reduced activation were noted. See
Methods and Table 2 for statistical details, p = 0.01 for cluster
depicted.
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vated during the mental rotation task and extend these
findings to reveal potential interactions with hormone
levels.
In addition to changes observed in the object rotation
task, we also observed changes in neural activation from
ADT during the recognition portion of the environmen-
tal memory task. Encoding of the complex environments
have been reliably shown to activate fusiform gyrus,
anterior and posterior superior parietal cortex, medial
frontal cortex, and occipital cortex [21,40] similar to
patterns of activation observed for the present study.
However, only the ADT group demonstrated a decrease
in task-related activity at month 9 of androgen depriva-
tion treatment compared to baseline in the right parietal
lobe during the recognition portion of the EMT while
both groups had decreased task-related activation during
encoding. Both the environmental memory task and the
mental rotation matching task have been shown to acti-
vate the parietal region and there is some suggestion
that this region may be related to spatial transformation
processes (See [40] for discussion).
Studies utilizing positron emission tomography (PET)
techniques have also reported changes in neural activa-
tion in response to changes ina n d r o g e nl e v e l s .H y p o g o -
nadal (low testosterone) men demonstrate increases in
cerebral glucose metabolism after 12 weeks of testoster-
one treatment compared in occipital and frontal regions
while performing a mental rotation task as measured by
F-18-deoxyglucose (FDG) PET [41]. A longitudinal study
of healthy, eugonadal older men found that higher free
testosterone (T) levels were related with increased regio-
nal cerebral blood flow (rCBF) as measured by serial
[
15O] PET in the hippocampus bilaterally, anterior cingu-
late gyrus and right inferior frontal cortex during resting
state [42]. A recent study of testosterone supplementa-
tion in eugonadal men reported both increases and
decreases in regional cerebral blood flow (rCBF) as mea-
sured by [F-18] fluorodeoxy glucose (FDG) while per-
forming a verbal memory recognition task [43].
Testosterone treatment resulted in increased glucose uti-
lization in left entorhinal cortex, right posterior hippo-
campus and right parahippocampal gyrus areas and
decreased glucose utilization in right entorhinal cortex/
amygdala. A single summary of findings from these stu-
dies is difficult given the wide variation of tasks from spa-
tial to verbal and resting state as well as populations
ranging from eugonadal and hypogonadal. However,
there does appear to be general support for a modulation
of neural activity in response to manipulation of andro-
gens. A consistent pattern of findings amongst studies
likely awaits further replication of hormone manipula-
tion, imaging technique and cognitive task.
Figure 2 Reduced task-related activation in individual subjects
during encoding, recognition and rotation at time2. Task
specific ROIs were defined by significant activation (over crosshair
viewing) during the individual tasks in a mixed-effects GLM and the
average Z-scores within these regions were determined for each
subject (and for each task) at time1 and time2. For each subject, the
difference in average z-scores was calculated (time2 - time1) and
thus negative scores represent a decrease in task-related activation
within an individual. Each point represents time2 - time1 from a
single subject. See Table 2 for statistical details.
Table 2 ACTIVATION CHANGES IN THE RIGHT PARIETAL AREA BETWEEN BASELINE (TIME 1) & TREATMENT (TIME 2)
Paradigm Contrast Brain region of cluster (all are right sided) Cluster
p-value
Area in
cm3
Z-max Z-max MNI
coordinates
All paradigms ADTTime1 > ADTtime2 precuneus, cuneus and lateral occipital lobe 0.011 4.72 4.15 26,-62,40
ENCODE ADTtime1 > ADTtime2 cuneus and lateral occipital lobe 0.006 3.9 4.37 22,-88,-4
precuneus 0.028 2.15 4.71 26,-68,44
CTRtime1 > CTRtime2 precuneus, cuneus and lateral occipital lobe 0.002 5.63 5.14 18,-72,46
RECOG ADTtime1 > ADTtime2 cuneus and precuneus 0.001 6.74 4.88 26,-64,36
ΔADT > ΔCTR precuneus 0.032 2.17 3.27 26,-64,36
MATCH ADTtime1 > ADTtime2 cuneus and precuneus 0.002 6.26 5.67 34,-90,8
ΔADT > ΔCTR precuneus 0.031 2.34 3.65 34,-82,32
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androgen levels may modulate neural activity, particu-
larly with regard to tasks that are spatially demanding
or require spatial transformation processing. In particu-
lar, declines in neural activity were evident only in the
ADT group compared to baseline and were most pro-
nounced for those tasks with spatial demand such as
three-dimensional rotation and the recall of the spatial
location of objects from the EMT. The clinical relevance
of these tasks relates to everyday tasks such as con-
structing or putting together furniture, household items
or building structures as well as map reading and navi-
gating which often require spatial or three dimensional
mental transformations. Although we have demon-
strated objective evidence of declines in spatial abilities
in men undergoing ADT [11,20], ideally these should
correspond to subjective reports of everyday task diffi-
culties. We are currently, investigating the nature of
subjective cognitive complaints in ADT patients. How-
ever, it is not unusual for patients to demonstrate poor
self or subjective appraisal of cognitive abilities such
that objective and subjective measurement do not match
(see for example [44-46]). This has also been observed
in cancer patients (e.g. Jacobs (2007) [47]) who may be
undergoing tremendous personal and health challenges.
The neuroimaging results provide further convergence
of evidence and a neural link with regard to our earlier
observed findings of declines in spatial abilities.
While these results are interesting the sample size was
limited. Thus, results will need to be independently
replicated with a larger sample. Nonetheless, the same
decline in task related activation following ADT was evi-
dent for both cognitive tasks thus lending some support
to consistency despite the small sample size along with
the study design which was prospective and repeated
measure thus there were two scans analyzed for each
subject. In addition, the study was prospective and
enrolled participants prior to the start of treatment, thus
establishing a clean baseline and the sample size is con-
sistent with other studies involving cancer patients and
neuroimaging (See McDonald et al. (2008) [48] for a
review) or studies involving coordination of neuroima-
ging along with treatment. An additional consideration
is that the sample was highly educated (mean of 17
years). This may have had an impact on the participants’
ability to perform the cognitive tasks and may also pro-
vide considerations for the generalizabiltiy of the results
to the population of men with prostate cancer. However,
patients were range matched to controls for age and
education, which may have provided some control over
differences between the groups.
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